Please login to the form below

Not currently logged in
Email:
Password:

biologic

This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief

AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief

Mene Pangalos will be the leader of a new unified Research and Development unit for BioPharmaceuticals, ending the split between MedImmune biologics research and AstraZeneca’s small molecule research division.

Latest news

More from news
Approximately 18 fully matching, plus 512 partially matching documents found.

Latest Intelligence

  • Is China ready for a pharmaceutical gold rush?

    On top of that, several local firms including Junshi Biosciences, Innovent Biologics and Hengrui Medicine, are developing their own PD-1 I-O treatments that are expected to hit the market ... Innovent Biologics Inc raised HK$3.3bn ($421m) at a valuation

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    Imfinzi, competing in the hypercompetitive world of immuno-oncology, was developed by MedImmune, the company’s US-based biologics research division, while the two small molecule drugs were developed in the ... The third area is immuno-oncology (IO)

  • Deal Watch October 2018

    non‐biologic product post‐patent loss, highlighting the benefits of biologics in the long term and the complexities of developing and manufacturing them. ... $307m. Samsung Bioepis/. Merck &Co. Lusduna Nexvue follow‐on biologic. Termination. $155m.

  • Nudge-nudge, think-think Nudge-nudge, think-think

    The power of achieving the triad of capability, opportunity and peer endorsement is evidenced by a recent study into how to avoid retrograde outcomes when switching patients from biologics to biosimilars.

  • Making Europe a leader in bioscience: boosting trust and opening minds Making Europe a leader in bioscience: boosting trust and opening minds

    New disruptive innovation is changing the way we create value in healthcare: big data, artificial intelligence, the growing role of patients, the discovery of new materials and biologics, gene, cell and

More from intelligence
Approximately 2 fully matching, plus 72 partially matching documents found.

Latest appointments

More from appointments
Approximately 7 fully matching, plus 46 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 7 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics